Molecular interactions of a semisynthetic glycopeptide antibiotic with D-alanyl-D-alanine and D-alanyl-D-lactate residues

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 1, 1997, Pages 66-71

  Allen, Norris E ^a   LeTourneau, Deborah L ^a   Hobbs Jr , Joe N ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROORIENTICIN A; DEXTRO ALANINE DEXTRO ALANINE LIGASE; VANCOMYCIN;

ALKYLATION; ANTIMICROBIAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; DRUG EFFECT; DRUG RECEPTOR BINDING; GLYCOSYLATION; GROWTH INHIBITION; HYDROGEN BOND; MOLECULAR INTERACTION; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; RESIDUE ANALYSIS;

EID: 0031038392     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.1.66     Document Type: Article

References (46)

1. Allen, N. E., J. N. Hobbs, Jr., and T. I. Nicas. 1996. Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semi-synthetic glycopeptide antibiotic. Antimicrob. Agents Chemother. 40:2356-2362.
2. Allen, N. E., J. N. Hobbs, Jr., J. M. Richardson, and R. M. Riggin. 1992. Biosynthesis of modified peptidoglycan precursors by vancomycin-resistant Enterococcus faecium. FEMS Microbiol. Lett. 98:109-116.
3. Barna, J. C. J., and D. H. Williams. 1984. The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Ann. Rev. Microbiol. 38:339-357.
4. Beauregard, D. A., D. H. Williams, M. N. Gwynn, and D. J. C. Knowles. 1995. Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics. Antimicrob. Agents Chemother. 39:781-785.
5. Bugg, T. D. H., G. D. Wright, S. Dutka-Malen, M. Arthur, P. Courvalin, and C. T. Walsh. 1991. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins vanH and vanA. Biochemistry 30:10408-10415.
6. Chatterjee, A. N., and H. R. Perkins. 1966. Compounds formed between nucleotides related to the biosynthesis of bacterial cell wall and vancomycin. Biochem. Biophys. Res. Commun. 24:489-494.
7. Chu, Y.-H., L. Z. Avila, J. Gao, and G. M. Whitesides. 1995. Affinity capillary electrophoresis. Acc. Chem. Res. 28:461-468.
8. Chu, Y.-H., and G. M. Whitesides. 1992. Affinity capillary electrophoresis can simultaneously measure binding constants of multiple peptides to vancomycin. J. Org. Chem. 57:3524-3525.
9. Gerhard, U., J. P. Mackay, R. A. Maplestone, and D. H. Williams. 1993. The role of the sugar and chlorine substituents in the dimerization of vancomycin antibiotics. J. Am. Chem. Soc. 115:232-237.
10. Gomez, F. A., L. Z. Avila, Y.-H. Chu, and G. M. Whitesides. 1994. Determination of binding constants of ligands to proteins by affinity capillary electrophoresis: compensation for electroosmotic flow. Anal. Chem. 66: 1785-1791.
11. Groves, P., M. S. Searle, J. P. Mackay, and D. H. Williams. 1994. The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics. Structure 2:747-754.
12. Hammes, W. P., and F. C. Neuhaus. 1974. Biosynthesis of peptidoglycan in Gaffkya homari: role of the peptide subunit of uridine diphosphate-N-acetyl-muramyl-pentapeptide. J. Bacteriol. 120:210-218.
13. Handwerger, S., M. J. Pucci, K. J. Volk, J. Liu, and M. S. Lee. 1992. The cytoplasmic peptidoglycan precursor of vancomycin-resistant Enterococcus faecalis terminates in lactate. J. Bacteriol. 174:5982-5984.
14. Hobbs, J. N., Jr. Unpublished data.
15. Izaki, K., and J. L. Strominger. 1968. Biosynthesis of the peptidoglycan of bacterial cell walls. Purification and properties of two D-alanine carboxypeptidases from Escherichia coli. J. Biol. Chem. 243:3193-3201.
16. Johnson, K., C. Duze, J.-M. Frère, and J.-M. Ghuysen. 1975. β-Lactamses (Actinomycetes species). Methods Enzymol. 43:687-698.
17. Konings, W. N., A. Bisschop, M. Veenhuis, and C. A. Vermeulen. 1973. New procedure for the isolation of membrane vesicles of Bacillus subtilis and an electron microscopy study of their ultrastructure. J. Bacteriol. 116:1456-1465.
18. LeTourneau, D. L. Unpublished data.
19. LeTourneau, D. L., and N. E. Allen. Use of capillary electrophoresis to measure dimerization of glycopeptide antibiotics. Anal. Biochem, in press.
20. Leyh-Bouille, M., J.-M. Ghuysen, M. Nieto, H. Perkins, K. Schleifer, and O. Kandler. 1970. On the Streptomyses albus G DD carboxypeptidase mechanism of action of penicillin, vancomycin, and ristocetin. Biochemistry 9:2971-297.
21. Lim H.-K., Y. L. Hsieh, B. Ganem, and J. Henion. 1995. Recognition of cell-wall peptide ligands by vancomycin group antibiotics: studies using ion spray mass spectrometry. J. Mass Spectrom. 30:708-711.
22. Linsdell, H., C. Toiron, M. Bruix, G. Rivas, and M. Menéndez. 1996. Dimerization of A82846B. vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides. J. Antihiot. 49:181-193.
23. Mackay, J. P., U. Gerhard, D. A. Beauregard, R. A. Maplestone, and D. H. Williams. 1994. Dissection of the contributions toward dimerization of glycopeptide antibiotics. J. Am. Chem. Soc. 116:4573-4580.
24. Mackay, J. P., U. Gerhard, D. A. Beauregard, M. S. Westwell, M. S. Searle, and D. H. Williams. 1994. Glycopeptide antibiotic activity and the possible role of dimerization: a model for biological signaling. J. Am. Chem. Soc. 116:4581-4590.
25. Matsuhashi, M., I. Ohara, and Y. Yoshiyama. 1969. Inhibition of bacterial cell wall synthesis in vitro by enduracidin, a new polypeptide antibiotic. Agric. Biol. Chem. 33:134-137.
26. Messer, J., and P. E. Reynolds. 1992. Modified peptidoglycan precursors produced by glycopeptide-resistant enterococci. FEMS Microbiol. Lett. 94: 195-200.
27. Nagarajan, R. 1994. Structure-activity relationships of vancomycin antibiotics, p. 195-218. In R. Nagarajan (ed.). Glycopeptide antibiotics. Marcel Dekker, Inc., New York, N.Y.
28. Nagarajan, R. 1993. Structure-activity relationships of vancomycin-type glycopeptide antibiotics. J. Antibiot. 46:1181-1195.
29. Nguyen-Disteche, M., M. Leyh-Bouille, S. Pirlot, J.-M. Frère, and J.-M. Ghuysen. 1986. Streptomyces K15 DD-peptidase-catalysed reactions with ester and amide carbonyl donors. Biochem. J. 235:167-176.
30. Nicas, T. I., and N. E. Allen. 1994. Resistance and mode of action, p. 219-241. In R. Nagarajan (ed.). Glycopeptide antibiotics. Marcel Dekker, Inc., New York, N.Y.
31. Nicas, T. I., D. L. Mullen, J. E. Flokowitsch, D. A. Preston, N. J. Snyder, R. E. Stratford, and R. D. G. Cooper. 1995. Activity of the semisynthetic glycopeptide LY191145 against vancomycin-resistant enterococci and other gram-positive bacteria. Antimicrob. Agents Chemother. 39:2585-2587.
32. Nicas, T. I., C. Y. E. Wu, J. N. Hobbs, Jr., and N. E. Allen. 1989. Characterization of vancomycin resistance in Enteracoccus faecium and Enterococcus faecalis. Antimicrob. Agents Chemother. 33:1121-1124.
33. Nieto, M., and H. R. Perkins. 1971. Modifications of the acyl-D-alanyl-D-alanine terminus affecting complex-formation with vancomycin. Biochem. J. 123:789-803.
34. Nieto, M., and H. R. Perkins. 1971. Physiochemical properties of vancomycin and iodovancomycin and their complexes with diacetyl-L-lysyl-D-alanyl-D-alanine. Biochem. J. 123:773-787.
35. Nieto, M., R. Perkins, and P. E. Reynolds. 1972. Reversal by a specific peptide (diacetyl-αγ-L-diaminobutyryl-D-alanyl-n-alanine) of vancomycin inhibition in intact bacteria and coll-free preparations. Biochem. J. 126:139-149.
36. Perkins, H. R., and M. Nieto. 1974. The chemical basis for the action of the vancomycin group of antibiotics. Ann. N. Y. Acad. Sci. 235:348-363.
37. Popieniek, P. H., and R. F. Pratt. 1987. A fluorescent ligand for binding studies with glycopeptide antibiotics of the vancomycin class. Anal. Biochem. 165:108-113.
38. Reynolds, P. E. 1989. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 8:943-950.
39. Rolston, K. V. I., H. Nguyen, and M. Messer. 1990. In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer. Antimicrob. Agents Chemother. 34:2137-2141.
40. Roth, G. S., G. D. Shockman, and L. Daneo-Moore. 1971. Balanced macromolecular biosynthesis in "protoplasts" of Streptococcus faecatis. J. Bacteriol. 105:710-717.
41. Tanaka, H., R. Oiwa, S. Matsukura, and S. Omura. 1979. Amphomycin inhibits phospho-N-acetylmuramyl-pentapeptide translocase in peptidoglycan synthesis of Bacillus. Biochem. Biophys. Res. Commun. 86:902-908.
42. Uttley, A. H. C., C. H. Collins, J. Naidoo, and R. C. George. 1988. Vancomycin-resistant enterococci. Lancet i:57-58.
43. van Heijenoort, J. M., Y. van Heijenoort, and P. Welzer. 1988. Moenomycin: inhibitor of peptidoglycan polymerization in Escherichia coli, p. 549-557. In P. Actor, L. Daneo-Moore, M. L. Higgins, M. R. J. Salton, and G. D. Shockman (ed.), Antibiotic inhibition of bacterial cell surface assembly and function. American Society for Microbiology, Washington, D.C.
44. Waltho, J. P., and D. H. Williams. 1989. Aspects of molecular recognition: solvent exclusion and dimerisation of the antibiotic ristocetin when bound to a model bacterial cell-wall precursor. J. Am. Chem. Soc. 111:2475-2480.
45. Westwell, M. S., B. Bardsley, R. J. Dancer, A. C. Try, and D. H. Williams. 1996. Cooperativity in ligand binding expressed at a model cell membrane by the vancomycin group antibiotics. J. Chem. Soc. Chem. Commun. 1996:589-590.
46. Westwell, M. S., U. Gerhard, and D. H. Williams. 1995. Two conformers of the glycopeptide antibiotic teicoplanin with distinct ligand binding sites. J. Antibiot. 48:1292-1298.